Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients

NeuroReport

Volumn 14, Issue 10, 2003, Pages 1297-1300

  Tsang, Shirley W Y ^a,c   Lai, Mitchell K P ^b,d   Francis, Paul T ^e   Wong, Peter T H ^c   Spence, Ian ^d   Esiri, Margaret M ^f   Keene, Janet ^f   Hope, Tony ^f   Chen, Christopher P L H ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d University of Sydney   (Australia)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; Anxiety; Neocortex; Polymorphisms; Serotonin transporter

Indexed keywords

CITALOPRAM; RADIOLIGAND; SEROTONIN TRANSPORTER;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ANXIETY DISORDER; ARTICLE; AUTOPSY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HOMOZYGOSITY; HORMONE SYNTHESIS; HUMAN; LIGAND BINDING; MALE; MEDICAL ASSESSMENT; MENTAL PATIENT; NEOCORTEX; NERVE CELL; PRIORITY JOURNAL; PROMOTER REGION; SYMPTOM; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANXIETY; CARRIER PROTEINS; CASE-CONTROL STUDIES; CITALOPRAM; FEMALE; FRONTAL LOBE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NEOCORTEX; NERVE TISSUE PROTEINS; PROMOTER REGIONS (GENETICS); RADIOLIGAND ASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TEMPORAL LOBE; TRITIUM;

EID: 0043202611     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200307180-00002     Document Type: Article

References (24)

1. Hope T, Keene J, Fairburn CG et al. Br J Psychiatry 174, 39-44 (1999).
2. Mega MS, Cummings JL, Fiorello T and Gornbein J. Neurology 46, 130-135 (1996).
3. Chen CP, Alder JT, Bowen DM et al. J Neurochem 66, 1592-1598 (1996).
4. Kaufer DI, Cummings JL, Christine D et al. J Am Geriatr Soc 46, 210-215 (1998).
5. Steele C, Rovner B, Chase GA and Folstein M. Am J Psychiatry 147, 1049-1051 (1990).
6. Aletrino MA, Vogels OJ, VanDomburg PH and Ten Donkelaar HJ. Neurobiol Aging 13, 461-468 (1992).
7. Chen CP, Eastwood SL, Hope T et al. Neuropathol Appl Neurobiol 26, 347-355 (2000).
8. Lesch KP, Bengel D, Heils A et al. Science 274, 1527-1531 (1996).
9. Heils A, Teufel A, Petri S et al. J Neurochem 66, 2621-2624 (1996).
10. Hope T, Keene J, Gedling K et al. Int J Geriatr Psychiatry 12, 1062-1073 (1997).
11. Hope T and Fairburn CG. Psychol Med 22, 223-230 (1992).
12. Mirra SS, Heyman A, McKeel D et al. Neurology 41, 479-486 (1991).
13. Lai MK, Tsang SW, Francis PT et al. Neuroreport 13, 1175-1178 (2002).
14. Arranz B and Marcusson J. J Neural Transm 97, 27-40 (1994).
15. Agnel M, Esnaud H, Langer SZ, Graham D et al. Biochem Pharmacol 51, 1145-1151 (1996).
16. McPherson GA. J Pharmacol Methods 14, 213-228 (1985).
17. Hardy JA, Wester P, Winblad B et al. J Neural Transm 61, 253-264 (1985).
18. Barnes NM and Sharp T. Neuropharmacology 38, 1083-1152 (1999).
19. Stahl SM. J Affect Disord 51, 215-235 (1998).
20. Greenberg BD, Li Q, Lucas FR et al. Am J Med Genet 96, 202-216 (2000).
21. Jobst KA, Smith AD, Szatmari M et al. Lancet 343, 829-830 (1994).
22. Wilcock GK and Esiri MM. J Neurol Sci 56, 343-356 (1982).
23. Sukonick DL, Pollock BG, Sweet RA et al. Arch Neurol 58, 1425-1428 (2001).
24. Folstein Mf, Folstein SE and McHugh PR. J Psychiatr Res 12, 189-198 (1975).